Advertisement
Screener

Lantern Pharma Inc. (LTRN) Accounts Payable and Other Accrued Liabilities

1.9 / 5 stars · 13/34 Roast Me

Lantern Pharma Inc. Accounts Payable and Other Accrued Liabilities

Lantern Pharma Inc. (LTRN) had Accounts Payable and Other Accrued Liabilities of $664.53 thousand as of 2021-03-31, per its 10-Q filed 2021-05-03.

Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities

us-gaap:AccountsPayableAndOtherAccruedLiabilities · last filed 2021-05-03

  • 2021-03-31: Accounts Payable and Other Accrued Liabilities $664.53K.
  • 2020-12-31: Accounts Payable and Other Accrued Liabilities $552.34K.
  • 2020-09-30: Accounts Payable and Other Accrued Liabilities $814.56K.
  • 2020-06-30: Accounts Payable and Other Accrued Liabilities $467.99K.
Period endAccounts Payable and Other Accrued Liabilities
2021-03-31$664.53K
10-Q · filed 2021-05-03
2020-12-31$552.34K
10-Q · filed 2021-05-03
2020-09-30$814.56K
10-Q · filed 2020-10-29
2020-06-30$467.99K
10-Q · filed 2020-07-30
2019-12-31$489.29K
10-K · filed 2021-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
Korsana Biosciences, Inc. (CYCN)United States$0.016B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13